CytomX
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.About CTMX
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W.
CTMX Key Statistics
Stock Snapshot
CytomX(CTMX) stock is priced at $4.28, giving the company a market capitalization of 924.16M. It carries a P/E multiple of 463.74.
During the trading session on 2026-03-26, CytomX(CTMX) shares reached a daily high of $4.37 and a low of $4.11. At a current price of $4.28, the stock is +4.0% higher than the low and still -2.2% under the high.
Trading activity shows a volume of 3.44M, compared to an average daily volume of 23.04M.
Over the past 52 weeks, CytomX(CTMX) stock has traded between a high of $8.21 and a low of $0.40.
Over the past 52 weeks, CytomX(CTMX) stock has traded between a high of $8.21 and a low of $0.40.
CTMX News
Piper Sandler raised the firm’s price target on CytomX Therapeutics (CTMX) to $12 from $10 and keeps an Overweight rating on the shares. Updated Phase I data on...
New insider activity at CytomX Therapeutics ( (CTMX) ) has taken place on March 19, 2026. CytomX Therapeutics insiders have recently executed a series of notab...
...
Analyst ratings
100%
of 9 ratingsMore CTMX News
An update from CytomX Therapeutics ( (CTMX) ) is now available. On March 17, 2026, CytomX Therapeutics, Inc. entered into an underwriting agreement with a synd...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.